about
A new insight into hepatitis C vaccine developmentPathogenesis of hepatitis C during pregnancy and childhoodMinimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.Identification of a Naturally Occurring Recombinant Genotype 2/6 Hepatitis C VirusMorphine Withdrawal Enhances Hepatitis C Virus Replicon ExpressionProduction of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived CellsManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingHepatitis C Virus (HCV): Prevalence in a Gynecological Urgent Care Clinic PopulationHepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal HepatocytesMorphine Enhances Hepatitis C Virus (HCV) Replicon ExpressionGenetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, ChinaMolecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern ChinaMethamphetamine enhances Hepatitis C virus replication in human hepatocytesAssociations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infectionPrevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.SHepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factorsFactors Associated with Prevalent Hepatitis C Infection Among HIV-Infected Women with No Reported History of Injection Drug Use: The Women's Interagency HIV Study (WIHS)Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3eA systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto RicoComplete blood count, measures of iron status and inflammatory markers in inner-city African Americans with undiagnosed hepatitis C seropositivity.Hepatitis C for addiction professionals.Known and probable risk factors for hepatitis C infection: a case series in north-eastern Poland.Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, CaliforniaTherapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics.Self-assembling peptide nanotubes with antiviral activity against hepatitis C virusTreatment of hepatitis C virus infectionTattoos: a photo essay.The emerging nosocomial pathogens Cryptosporidium, Escherichia coli O157:H7, Helicobacter pylori, and hepatitis C: epidemiology, environmental survival, efficacy of disinfection, and control measures.Reducing HIV-related risk behaviors among injection drug users in residential detoxificationTreatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders.HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women.Validation of a sensitive LC/MS/MS method for the determination of telaprevir and its R-isomer in human plasma.Medical care and alcohol use after testing hepatitis C antibody positive at STD clinic and HIV test site screening programsA potential hidden source of hepatitis C infection among noninjecting drug users.Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.Prevention of hepatitis C virus infection.Injection behaviors among injection drug users in treatment: the role of hepatitis C awarenessPrevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--IranLiver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics
P2860
Q21296858-E999F5DD-EE84-498A-B6A1-A560C2639486Q22809427-91D7D2C7-FDB7-4553-907B-E78E4C57D9B2Q27471458-F7603EAB-EB73-4EC4-9F98-E31FE1BC4BC5Q27477460-2969E4D5-E3B4-4693-95A6-D8A6E7FC2367Q27477516-A7797545-E8E3-4220-BC5D-BDBC8F99B756Q27477544-FF54C6DC-6940-4520-97E3-535C61C90EA8Q27477626-0CE871D2-FB92-4FCD-98F2-C0AFB6346505Q27478008-F5456520-2D0B-409C-A163-0721C8925CF9Q27478288-2E7F70FB-66F2-4954-9445-65EDB3E771FDQ27478396-08C15DAE-2FB8-4111-8F3C-D2A5403F6157Q27486520-705C7997-5D3B-4BA1-BDA4-184AF1FDB5A0Q27487103-88279883-BC17-44AB-8961-2F7B8CAEB352Q27488356-F0FCFEC2-7E5C-4A32-B747-E1D61AB0F74FQ27488759-89B39C45-FD51-4715-846C-6336DEEF99B6Q27489610-5E4DFA9C-7736-4422-876C-AE585F27ACA4Q27490493-0985FC2A-39E8-4BF5-A103-E5ED25F7703DQ27490928-A5A86CA9-6FC6-46F1-8043-2FB288DE5B91Q28655567-3A80C705-B568-4923-8625-F57A586245A4Q30403548-789CD07C-929F-431F-ADCB-DF96AA3178E6Q33262182-45958D78-D00B-4A18-B0E8-EA50029A4FD9Q33388034-F29212A6-FE72-4D1A-A068-D0CA7C0A4BACQ33553099-464243E9-2562-4A12-9064-D682707371EAQ33829880-30CE69AE-E85E-42D4-9CB4-6B2417526B24Q33978978-C64CD19C-076F-41D8-88B2-CB090B37195FQ33999004-0432F85B-7A29-494E-BBF2-20DD44498A9EQ34084050-49D21438-880F-4673-92A0-A8AD407A1C99Q34099424-77A17560-165E-4771-99EB-82EBC5E89088Q34200267-C6977F24-3C61-4254-A8FB-67336B565FC3Q34294486-0C6EE757-64E8-4DAC-8CE4-B731D4868A6BQ34504608-A0F59AF2-F857-404A-87F4-4FE154975728Q34962752-A9D74B3C-2EE4-401F-A618-48C1E33A561AQ35056682-FFC7147A-F8F9-4ED7-A05C-9539B94AB035Q35156383-35356D8B-6327-4303-9B00-43416AAE0991Q35646006-55572FED-1FB1-4AE5-A078-B88628366430Q35676808-7F4F1457-775F-4227-BC5A-D92DCA7F14BDQ35711956-A8A1D0A0-28B2-422E-9F59-9C826251A932Q35760264-5B509137-3F84-452E-8888-F1CEA1775FE9Q35784012-6E6523C6-EA9C-44C0-8E52-79D3596F5865Q35851167-45A68B10-B3A6-4A47-B81D-5D4AA39F2D0EQ36035550-CBE7225B-A922-4073-BE1A-26F96BCA2F61
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Hepatitis C virus infection in the United States.
@ast
Hepatitis C virus infection in the United States.
@en
type
label
Hepatitis C virus infection in the United States.
@ast
Hepatitis C virus infection in the United States.
@en
prefLabel
Hepatitis C virus infection in the United States.
@ast
Hepatitis C virus infection in the United States.
@en
P1476
Hepatitis C virus infection in the United States.
@en
P2093
P356
10.1016/S0168-8278(99)80381-X
P478
31 Suppl 1
P577
1999-01-01T00:00:00Z